These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14647532)

  • 1. CVT-510: a selective A1 adenosine receptor agonist.
    Cheung JW; Lerman BB
    Cardiovasc Drug Rev; 2003; 21(4):277-92. PubMed ID: 14647532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tecadenoson: a novel, selective A1 adenosine receptor agonist.
    Peterman C; Sanoski CA
    Cardiol Rev; 2005; 13(6):315-21. PubMed ID: 16230891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INO-8875, a highly selective A1 adenosine receptor agonist: evaluation of chronotropic, dromotropic, and hemodynamic effects in rats.
    Mor M; Shalev A; Dror S; Pikovsky O; Beharier O; Moran A; Katz A; Etzion Y
    J Pharmacol Exp Ther; 2013 Jan; 344(1):59-67. PubMed ID: 23055540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans.
    Lerman BB; Ellenbogen KA; Kadish A; Platia E; Stein KM; Markowitz SM; Mittal S; Slotwiner DJ; Scheiner M; Iwai S; Belardinelli L; Jerling M; Shreeniwas R; Wolff AA
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):237-45. PubMed ID: 11584330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial Adenosine A1 Agonist in Heart Failure.
    Dinh W; Albrecht-Küpper B; Gheorghiade M; Voors AA; van der Laan M; Sabbah HN
    Handb Exp Pharmacol; 2017; 243():177-203. PubMed ID: 27770217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson.
    Ellenbogen KA; O'Neill G; Prystowsky EN; Camm JA; Meng L; Lieu HD; Jerling M; Shreeniwas R; Belardinelli L; Wolff AA;
    Circulation; 2005 Jun; 111(24):3202-8. PubMed ID: 15956124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig.
    Snowdy S; Liang HX; Blackburn B; Lum R; Nelson M; Wang L; Pfister J; Sharma BP; Wolff A; Belardinelli L
    Br J Pharmacol; 1999 Jan; 126(1):137-46. PubMed ID: 10051130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist.
    Prystowsky EN; Niazi I; Curtis AB; Wilber DJ; Bahnson T; Ellenbogen K; Dhala A; Bloomfield DM; Gold M; Kadish A; Fogel RI; Gonzalez MD; Belardinelli L; Shreeniwas R; Wolff AA
    J Am Coll Cardiol; 2003 Sep; 42(6):1098-102. PubMed ID: 13678937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CVT-510 (CV Therapeutics).
    Zaza A
    Curr Opin Investig Drugs; 2002 Jan; 3(1):96-100. PubMed ID: 12054080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adenosine, its analogues and conjugates].
    Samsel M; Dzierzbicka K; Trzonkowski P
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1189-203. PubMed ID: 24379260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial A(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF).
    Zablocki JA; Wu L; Shryock J; Belardinelli L
    Curr Top Med Chem; 2004; 4(8):839-54. PubMed ID: 15078215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Janus face of adenosine: antiarrhythmic and proarrhythmic actions.
    Szentmiklosi AJ; Galajda Z; Cseppento Á; Gesztelyi R; Susán Z; Hegyi B; Nánási PP
    Curr Pharm Des; 2015; 21(8):965-76. PubMed ID: 25354187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiac effects of a novel A1-adenosine receptor agonist in guinea pig isolated heart.
    Belardinelli L; Lu J; Dennis D; Martens J; Shryock JC
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1371-82. PubMed ID: 7996449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.
    Schindler CW; Karcz-Kubicha M; Thorndike EB; Müller CE; Tella SR; Ferré S; Goldberg SR
    Br J Pharmacol; 2005 Mar; 144(5):642-50. PubMed ID: 15678095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of two selective A
    Cooper SL; March J; Sabbatini AR; Hill SJ; Jörg M; Scammells PJ; Woolard J
    Br J Pharmacol; 2020 Jan; 177(2):346-359. PubMed ID: 31596949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells.
    Nakashima KI; Iwao K; Inoue T; Haga A; Tsutsumi T; Mochita MI; Fujimoto T; Tanihara H
    Exp Eye Res; 2018 May; 170():160-168. PubMed ID: 29486164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine as a therapeutic agent.
    Mosqueda-Garcia R
    Clin Invest Med; 1992 Oct; 15(5):445-55. PubMed ID: 1458718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists.
    Gao Z; Li Z; Baker SP; Lasley RD; Meyer S; Elzein E; Palle V; Zablocki JA; Blackburn B; Belardinelli L
    J Pharmacol Exp Ther; 2001 Jul; 298(1):209-18. PubMed ID: 11408544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
    Honerjäger P; Schmidt G
    Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.